VJHemOnc is committed to improving our service to you

CAR-T ICU 2019 | Neurology needs: preparing neurologists for CAR-T

VJHemOnc is committed to improving our service to you

Robert Hadden

Robert Hadden, BM BCh, FRCP, PhD, King’s College Hospital, London, UK, discusses future directions for managing symptoms of neurotoxicity in CAR T-cell treated patients. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter